Back to results
CompletedPhase 2Phase 3

NRX101 Glx Biomarker Validation Study

NCT03402152

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

New York State Psychiatric Institute

New York, New York, United States

View on ClinicalTrials.gov